6th September, 2023
Prof. Tina Hartert
Prof. Dr. Louis Bont
read moreWebinar Series
Webinars for the general public
We also offer a webinar series for the general public.
Latest webinar:
“RSV and Asthma”
Our latest ReSViNET Webinar was on the 6th of September with Prof Tina Hartert, MD, MPH, as our guest speaker. She shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life respiratory syncytial virus (RSV) decreases the risk of developing childhood asthma. These findings underscore the role of RSV in both acute and chronic respiratory disease and pave the way for asthma prevention efforts.
Previous webinars:
Progress in RSV vaccines and monoclonal antibodies
The public health perspective on RSV
Treating children with RSV: from ethanol to EDP-938
RSV Epidemiology after COVID
RSV interaction with bacteria
RSV-related community mortality
17th September, 2021
Dr Natalie Mazur
Padmini Srikantiah and Prof Dr Louis Bont
Approximately 50% of RSV-related mortality occurs in the community; this webinar...
Airway smooth muscle dysfunction in RSV infection
30th June, 2021
Dr Giovanni Piedimonte
Prof Larry J. Anderson and Prof Dr Louis Bont
Dr. Giovanni Piedimonte's presentation will be based on his paper in Science...
Detection of defective viral genomes as a potential tool to predict Respiratory Syncytial Virus clinical outcome
27th May, 2021
Prof Carolina B. Lopez
Dr Ulla Buchholz and Prof Dr Louis Bont
This webinar focused on the detection of defective viral genomes (DVGs)....
RSV dynamics during the COVID-19 pandemic
25th March, 2021
Dr Dan Weinberger
Dr Renato Stein and Prof Dr Louis Bont
This webinar is focused on the spatiotemporal variation in epidemic timing of...